E EDGEWISE THERAPEUTICS INC
| Market Cap | $3.04B |
| P/E Ratio | — |
| Forward P/E | -12.26 |
| Dividend Yield | — |
| Beta | 0.27 |
| 52W Range | $10.60 - $31.82 |
| # Hedge Funds | 0 |
| Sector | Healthcare |
| Industry | Biotechnology |
Hedge Fund Ownership
| Investor 0 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|
Insider Trading
| Insider Name of the company insider who made the trade 11 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Donovan Joanne M.CMO | Sale | 28,662 | $32.31 | $926.10K | 01 Apr 2026 | 01 Apr 2026 |
| Joanne M. DonovanCMO | Sale | 21,338 | $32.12 | $685.31K | 31 Mar 2026 | 31 Mar 2026 |
| Joanne M. DonovanCMO | Sale | 6,735 | $30.98 | $208.64K | 27 Mar 2026 | 30 Mar 2026 |
| Joanne M. DonovanCMO | Sale | 9,623 | $30.98 | $298.10K | 27 Mar 2026 | 30 Mar 2026 |
| Edris Badreddin | Sale | 66,477 | $29.44 | $1.96M | 21 Jan 2026 | 23 Jan 2026 |
| Edris Badreddin | Sale | 10,463 | $29.44 | $308.03K | 21 Jan 2026 | 23 Jan 2026 |
| Edris Badreddin | Sale | 7,605 | $29.44 | $223.89K | 21 Jan 2026 | 23 Jan 2026 |
| Edris Badreddin | Sale | 17,236 | $29.44 | $507.43K | 21 Jan 2026 | 23 Jan 2026 |
| Edris Badreddin | Sale | 13,690 | $29.44 | $403.03K | 21 Jan 2026 | 23 Jan 2026 |
| Russell Alan JChief Scientific Officer | Sale | 100,000 | $21.12 | $2.11M | 12 Nov 2025 | 13 Nov 2025 |
| Fox Jonathan C | Buy | 10,700 | $18.64 | $199.40K | 11 Nov 2025 | 13 Nov 2025 |
Frequently Asked Questions
What is EWTX stock price today?
EDGEWISE THERAPEUTICS INC (EWTX) is currently trading at $28.35. The stock has a 52-week range of $10.60 to $31.82 and a market capitalization of $3.04B.
Is EWTX a good stock to buy in 2026?
EDGEWISE THERAPEUTICS INC has a P/E ratio of N/A (forward P/E: N/A), a dividend yield of none, and 1-year performance of +2.7%. 0 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling EWTX stock?
There have been 11 insider transactions for EWTX in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has EWTX stock performed over the past year?
EDGEWISE THERAPEUTICS INC (EWTX) has returned +2.7% over the past 12 months. The stock traded between $10.60 and $31.82 during this period, and is currently at $28.35.
Which hedge funds own EWTX (EDGEWISE THERAPEUTICS INC)?
0 tracked hedge funds currently hold EWTX in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is EWTX's market cap and valuation?
EDGEWISE THERAPEUTICS INC (EWTX) has a market capitalization of $3.04B. The trailing P/E ratio is N/A and forward P/E is N/A. The stock is classified in the Healthcare sector.
What is EWTX's revenue and profitability?
EDGEWISE THERAPEUTICS INC reported revenue of N/A with net income of N/A and a profit margin of N/A. The stock has a beta of 0.27.
What sector is EWTX in and who are its biggest institutional holders?
EDGEWISE THERAPEUTICS INC (EWTX) operates in the Healthcare sector. It is held by 0 tracked hedge funds. See the ownership table above for the complete list.